Gemmill, Marin C., Thomson, Sarah and Mossialos, Elias (2008) What impact do prescription drug charges have on efficiency and equity?: evidence from high-income countries. International journal for equity in health, 7 (12). ISSN 1475-9276
As pharmaceutical expenditure continues to rise, third-party payers in most high-income countries have increasingly shifted the burden of payment for prescription drugs to patients. A large body of literature has examined the relationship between prescription charges and outcomes such as expenditure, use, and health, but few reviews explicitly link cost sharing for prescription drugs to efficiency and equity. This article reviews 173 studies from 15 high-income countries and discusses their implications for important issues sometimes ignored in the literature; in particular, the extent to which prescription charges contain health care costs and enhance efficiency without lowering equity of access to care.
|Additional Information:||© 2008 The Authors; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.|
|Library of Congress subject classification:||R Medicine > RA Public aspects of medicine|
|Sets:||Research centres and groups > LSE Health|
Actions (login required)
|Record administration - authorised staff only|